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ABSTRACT In Trypanosoma brucei and related kinetoplastid parasites, transcription
of protein coding genes is largely unregulated. Rather, mRNA binding proteins,
which impact processes such as transcript stability and translation efﬁciency, are the
predominant regulators of gene expression. Arginine methylation is a posttransla-
tional modiﬁcation that preferentially targets RNA binding proteins and is, therefore,
likely to have a substantial impact on T. brucei biology. The data presented here
demonstrate that cells depleted of T. brucei PRMT1 (TbPRMT1), a major type I pro-
tein arginine methyltransferase, exhibit decreased virulence in an animal model. To
understand the basis of this phenotype, quantitative global proteomics was em-
ployed to measure protein steady-state levels in cells lacking TbPRMT1. The ap-
proach revealed striking changes in proteins involved in energy metabolism. Most
prominent were a decrease in glycolytic enzyme abundance and an increase in pro-
line degradation pathway components, changes that resemble the metabolic remod-
eling that occurs during T. brucei life cycle progression. The work describes several
RNA binding proteins whose association with mRNA was altered in TbPRMT1-
depleted cells, and a large number of TbPRMT1-interacting proteins, thereby high-
lighting potential TbPRMT1 substrates. Many proteins involved in the T. brucei star-
vation stress response were found to interact with TbPRMT1, prompting analysis of
the response of TbPRMT1-depleted cells to nutrient deprivation. Indeed, depletion of
TbPRMT1 strongly hinders the ability of T. brucei to form cytoplasmic mRNA granules
under starvation conditions. Finally, this work shows that TbPRMT1 itself binds nu-
cleic acids in vitro and in vivo, a feature completely novel to protein arginine meth-
yltransferases.
IMPORTANCE Trypanosoma brucei infection causes human African trypanosomiasis,
also known as sleeping sickness, a disease with a nearly 100% fatality rate when un-
treated. Current drugs are expensive, toxic, and highly impractical to administer,
prompting the community to explore various unique aspects of T. brucei biology in
search of better treatments. In this study, we identiﬁed the protein arginine methyl-
transferase (PRMT), TbPRMT1, as a factor that modulates numerous aspects of T. bru-
cei biology. These include glycolysis and life cycle progression signaling, both of
which are being intensely researched toward identiﬁcation of potential drug targets.
Our data will aid research in those ﬁelds. Furthermore, we demonstrate for the ﬁrst
time a direct association of a PRMT with nucleic acids, a ﬁnding we believe could
translate to other organisms, including humans, thereby impacting research in ﬁelds
as distant as human cancer biology and immune response modulation.
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Trypanosoma brucei is a parasitic protozoan causing African sleeping sickness insub-Saharan Africa. An estimated 70 million people are at risk of the infection, and
WHO estimates roughly 20,000 new cases per year when likely underreporting is taken
into account (1). Furthermore, animal trypanosomiasis in the African region constitutes
a large economic burden. It is estimated that dealing with trypanosomiasis would result
in a beneﬁt of approximately 2.5 billion USD to livestock keepers in affected regions
over a 20-year period (2). The parasite is transmitted between the mammalian hosts via
an insect vector, the tsetse ﬂy (Glossina spp.). Throughout its life cycle, T. brucei changes
both its morphology and physiology to adjust to nutritional and immunological
conditions encountered in the hosts. The bloodstream form (BF) that thrives in mam-
malian blood utilizes glycolysis, compartmentalized in a specialized organelle called a
glycosome, as the main energy source (3). BF cells employ a quorum sensing mecha-
nism to detect a high parasite load and transform to a nondividing stumpy stage that
is preadapted to life in the insect vector (4). Once taken up by the ﬂy, parasites progress
through the life cycle, further changing their physiology. The procyclic form (PF)
inhabiting the ﬂy’s midgut turns to proline degradation coupled to the TCA cycle to
cope with the lack of glucose in its environment (5). These changes are reﬂected in the
size of the parasite’s single mitochondrion, which in PF takes up much of the cytoplas-
mic space, as well as in the utilization of oxidative phosphorylation, which is almost
exclusively active in PF. The changes T. brucei undergoes through its life cycle are
almost solely controlled at the posttranscriptional level, since T. brucei utilizes polycis-
tronic transcription of functionally unrelated genes and subsequently generates indi-
vidual mRNAs through the processes of 5= trans-splicing and 3= cleavage and polyad-
enylation (6). The major means of gene regulation are embodied in the mRNA binding
proteome, which in turn is regulated by a multitude of mechanisms, including post-
translational modiﬁcations (PTM). Protein arginine methylation is a PTM that dispro-
portionally targets RNA binding proteins in T. brucei as well as in mammals (7–9).
Arginine methylation, which in T. brucei affects about 15% of the proteome, is catalyzed
by protein arginine methyltransferases (PRMTs) that can be classiﬁed into three types
based on the end products of their catalytic activities (7, 8, 10). All three types can
catalyze the formation of -NG-monomethylarginine (MMA). While type III PRMTs are
limited to this modiﬁcation, type I PRMTs can catalyze formation of -NG,NG-asymmetric
dimethylarginine (ADMA), and type II PRMTs create -NG,N=G-symmetric dimethylargi-
nine (SDMA). T. brucei harbors four PRMTs that represent all three types and engage in
a functional interplay (11).
T. brucei PRMT1 (TbPRMT1) is a type I PRMT that we previously showed catalyzes the
majority of ADMA formation in vivo (12). TbPRMT1 inﬂuences the functions of proteins
involved in RNA editing and controls the mRNA-stabilizing and -destabilizing functions
of the RNA binding protein DRBD18 in PF T. brucei (12–16). However, more global
impacts on cell function have not been investigated, and TbPRMT1 function has not
been examined in BF T. brucei. TbPRMT1 structure is highly unusual since, unlike other
characterized type I PRMTs that form homodimers or homomultimers, it functions as a
heterotetramer of an enzymatic subunit (ENZ) and a catalytically inactive PRMT paralog
termed prozyme (PRO) (13, 17–20). The two TbPRMT1 subunits mutually stabilize each
other on the protein level, and while the PRO subunit does not carry out catalysis, it is
indispensable for TbPRMT1 function.
Here, we examine the in vivo role and in vitro properties of TbPRMT1 using a mouse
model and biochemical, cell biological, and global proteomic strategies in BF and PF T.
brucei. Our results show that although TbPRMT1 is not strictly needed for BF T. brucei
growth in culture, the protein contributes to T. brucei virulence in an animal model. We
further show that in the absence of TbPRMT1, the BF parasites downregulate enzymes
involved in glycolysis and upregulate pathways that utilize alternative energy sources.
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We quantiﬁed changes in the mRNA-bound proteome and identiﬁed several proteins
whose association with mRNA is signiﬁcantly altered in the TbPRMT1-depleted back-
ground. In the attempt to identify TbPRMT1 in vivo substrates, we noted an overrep-
resentation of stress-related proteins associating with TbPRMT1. We conﬁrmed the
biological signiﬁcance of this ﬁnding by demonstrating a defect in mRNA granule
formation during nutritional stress in PF cells depleted for TbPRMT1. Finally, we show
that TbPRMT1 itself is able to associate with nucleic acids, which is a completely novel
feature in this class of enzymes. Thus, the present studies reveal that TbPRMT1 plays
signiﬁcant roles in trypanosome virulence, metabolism, and RNA biology.
RESULTS
Knockout of the TbPRMT1 enzymatic subunit leads to growth retardation and
decreases parasite virulence.We began by establishing whether TbPRMT1 is essential
for T. brucei survival in the mammalian host. As an RNAi-based knockdown had no
effect on BF growth in vitro (data not shown), we generated a TbPRMT1 knockout (KO)
cell line in BF T. brucei to unequivocally determine whether the enzyme plays a role in
virulence. Two alleles of the TbPRMT1 ENZ subunit were replaced with blasticidin and
puromycin resistance cassettes, whose incorporation into the genome was conﬁrmed
by PCR on genomic DNA using both TbPRMT1 untranslated region (UTR)-based and
open reading frame (ORF)-based primers (Fig. 1A). Growth of wild-type (WT) and KO cell
lines was then measured over the course of 11 days, and a mild but reproducible
growth phenotype was observed (Fig. 1B). To ascertain whether this phenotype could
be attributed to the loss of TbPRMT1 or whether it should be ascribed to cell-line-
speciﬁc differences, we complemented the KO with the ENZ subunit of TbPRMT1
exogenously expressed under doxycycline control. We expressed the exogenous ENZ
for 2 weeks and then monitored growth over a 3-day period. We calculated doubling
times of WT, ENZ KO, and ENZ KOAB (add-back) cell lines and determined that the
mild growth phenotype could indeed be attributed to the loss of TbPRMT1 (Fig. 1C).
Next we conﬁrmed that the exogenous ENZ also restores the arginine methyl landscape
of BF trypanosomes (Fig. 1D). We probed WT, ENZ KO, and ENZ KOAB cell lysates with
anti-ENZ, anti-ADMA, and anti-MMA antibodies. We saw that loss of ENZ leads to a
steep increase in proteins bearing the MMA mark, a phenomenon previously observed
in both mammals and T. brucei (11, 21). We also observed a modest decrease in proteins
recognized by the anti-ADMA antibody. It is important to note that the anti-ADMA
antibody recognizes only a small number of all proteins bearing the ADMA mark in the
cell. In previous studies we found that while the observed decrease of proteins
recognized by this antibody is modest, the increase of proteins bearing the MMA mark
is quite striking (11). Upon exogenous expression of ENZ, the ADMA proﬁle fully
corresponded to the WT landscape. The MMA proﬁle mostly corresponded to the WT
landscape. Therefore, we conclude that the changes in methyl landscape in the ENZ KO
cell line can be attributed to the loss of TbPRMT1. Having established the ENZ KO strain,
we infected mice with either WT or ENZ KO T. brucei to determine the impact of
TbPRMT1 in a living system. We found that ENZ KO leads to a signiﬁcantly prolonged
life expectancy of T. brucei-infected mice compared to WT (Fig. 1E, P 0.05). Therefore,
TbPRMT1 contributes to T. brucei virulence through an unknown mechanism, which
may be connected to the lower growth rate of ENZ KO cells in vitro.
TbPRMT1 knockout leads to changes in metabolic enzyme expression and
changes mRNA association of a small subset of proteins. RNA binding proteins are
a major protein group targeted by PRMTs across the evolutionary spectrum (7–9, 22).
Although arginine methylation of RNA binding proteins has mostly been shown to alter
protein-protein interactions, examples of altered afﬁnity for RNA upon modulation of
arginine methylation state have been reported (9, 22–24). Since RNA binding proteins
constitute the major means of regulating the T. brucei proteome, we asked whether the
lack of TbPRMT1 alters the association of certain proteins with mRNA. To this end, we
isolated the mRNA-bound proteome from WT and ENZ KO cell lines and subjected the
eluates to quantitative mass spectrometry. We anticipated that any observed changes
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in the mRNA-bound proteome could be attributed to either altered mRNA association
or altered protein abundance in the cell. In order to discriminate between these two
possibilities, we ﬁrst established steady-state abundances of proteins in WT and ENZ KO
cell lines by quantitative mass spectrometry analysis. We identiﬁed 4,856 proteins out
of the 9,598 currently annotated in the TriTryp database as protein coding. We saw that
385 proteins decreased in abundance (1.5-fold, P 0.05) and 167 proteins increased
their abundance (1.5-fold, P 0.05) in the KO compared to WT (see Table S1 in the
supplemental material). We conﬁrmed these changes by Western blotting for several
proteins that did not change in abundance; MRB800, which decreased in abundance;
and UMSBP1, which increased in abundance (Fig. 2A and Fig. S1). Further analysis of the
data set revealed alterations in the levels of proteins involved in various aspects of T.
brucei biology such as cell division, DNA repair and replication, RNA synthesis and
processing, translation, the ubiquitin system, and vesicular transport. We also noted
numerous remarkable alterations in the abundances of proteins involved in energy
metabolism, some of which suggested possible pathway coregulation and life cycle-
speciﬁc regulation. For example, ENZ KO leads to upregulation of several enzymes in
the proline degradation pathway (Fig. 2B and Table 1). Interestingly, the mRNAs
encoding all of the enzymes needed to obtain energy from the oxidation of proline to
succinate are bound by a common RBP, DRBD3 (25). We identiﬁed signiﬁcant overlap
FIG 1 TbPRMT1 contributes to T. brucei virulence. (A) (Left) Schematic representation of the knockout (KO) strategy. Arrows indicate primer placement. (Right)
KO conﬁrmation by PCR of genomic DNA from two different clones. (B) Growth of WT and ENZ KO cell lines in culture. Cumulative cell density over time was
plotted. Each point represents the mean for two clones in duplicate. Error bars indicate standard deviation. (C) Doubling time of WT, ENZ KO, and ENZ KOAB
(add-back) cells either uninduced (dox-) or induced for expression of exogenous ENZ (dox) was calculated. Two clones of each cell line were used. Mean
(n  3) is plotted. Error bars show standard deviation. *, P 0.05; **, P 0.005; ***, P 0.0005. (D) Western blot assays in which the indicated antibodies were
used to assay levels of endogenous and exogenous ENZ and visualize the methyl landscape of indicated cell lines. * marks a nonspeciﬁc band recognized by
the anti-ENZ antibody. HSP70 is a load control. (E) Virulence assay. Mice were infected with the WT or ENZ KO strain. Time of death postinfection is plotted.
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between DRBD3-bound transcripts and proteins upregulated in ENZ KO (P 0.009),
suggesting that this RBP may mediate a subset of the changes observed in Table 1. The
proline degradation pathway is typically utilized in PF T. brucei cells that lack access to
glucose (5), leading us to examine other metabolic pathways whose utilization is
altered during the T. brucei life cycle. We observed an upregulation of certain subunits
of respiratory chain complexes and farnesyl pyrophosphate synthase, which is involved
in synthesis of CoQ (Table 1). The most prominent increase in abundance was noted in
the citric acid cycle, namely, in the level of citrate synthase, which increased 10-fold. We
also noted a marked decrease in enzymes participating in the major pathway of energy
production in BF T. brucei: glycolysis. Speciﬁcally, hexokinase, the enzyme responsible
for glucose commitment to glycolysis, decreased in abundance to about 50% of WT
levels. Similar decreases were noted in the levels of glucose-6-phosphate isomerase, an
enzyme working directly downstream of hexokinase, and in alanine aminotransferase.
Alanine aminotransferase is responsible for conversion of pyruvate to alanine, a path-
way that is extensively utilized in BF trypanosomes (26). We also noticed a decrease in
several enzymes with putative roles in inositol metabolism (Table 1, “other metabolism-
related genes”). Three out of four T. brucei fatty acyl CoA synthetases and glycerol-3-
phosphate acyltransferase decreased in abundance, indicating a decrease in the rate of
de novo lipid synthesis that utilizes free fatty acids and glycerol. Possibly related to
FIG 2 TbPRMT1 knockout leads to metabolic reprogramming. (A) Western blot conﬁrmation of changes in protein levels detected by quantitative
mass spectrometry. (Top) Representative Western blot of indicated proteins. Load control, whole-protein Revert staining. (Bottom) Quantiﬁcation
of protein levels. An equation of trendline describing expected antibody signal per Revert signal in WT cells was obtained (Fig. S1). Expected
antibody signal for each experimental sample was calculated using Revert signal. Shown is the mean from two biological and two technical
replicates of actual/expected signal, with error bars denoting standard deviation. P values were calculated using a two-tailed t test. **, P 0.005;
***, P 0.0005. (B) Schematic representation of metabolic changes in ENZ KO cells. Green, pathways upregulated in ENZ KO. Red, pathways
downregulated in ENZ KO. Red crosses indicate positions of major blocks in the pathways. Dashed green circle indicates upregulated membrane
transporter. CS, citrate synthase; 2-Ket, -ketoglutarate; GLU, glutamic acid; GLN, glutamine. (C) Western blot of bloodstream-form WT (WT BF),
ENZ KO BF, and procyclic-form strain 29-13 (WT PF) cells using an antibody that recognizes PAD2. Arrow indicates PAD2 signal. Load control,
whole-protein Revert staining.
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these changes could be the roughly 50% decrease in aquaglyceroporin 2 (AQP2)
channel abundance. AQP2 is a glycerol transporter residing in the T. brucei cell
membrane that has been linked to drug resistance in African trypanosomes (27).
Overall, the observed changes in metabolism resembled those typically observed
during the transition from BF to PF. However, when we compared the entire data set
to proteins previously shown to be up-/downregulated in PF or BF, we did not see a
signiﬁcant overlap with those that change upon ENZ KO (28). We did, however, observe
an increase in PAD2, a protein involved in conveying the differentiation signal in the
BF-to-PF life cycle transition (29). PAD2 is absent from the long slender BF stage,
increases in abundance in the stumpy stage, and remains on the surface once the cells
progress to the PF stage. We wanted to verify the increase in PAD2 in BF upon ENZ KO
through Western blotting using anti-PAD2 antibodies (29). We were unable to quan-
titate the increase due to the absence of PAD2 signal in our WT BF cells. However, we
do clearly observe a detectable amount of PAD2 in ENZ KO cells, validating the increase
in this key differentiation molecule (Fig. 2C). Overall, we conclude that the loss of ENZ
leads to a dysregulation of T. brucei metabolism. This effect may be achieved through
TABLE 1Metabolism-related proteins that were identiﬁed by mass spectrometry as having altered abundance in ENZ KO cell line
Gene ID Product name KO/WT P value
Proline metabolism
Tb927.10.13120 TbMCP14 mitochondrial proline transporter 2.13 4.25E02
Tb927.7.210 Proline dehydrogenase 1.95 1.01E05
Tb927.9.5900 Glutamate dehydrogenase 1.77 3.93E04
Tb927.11.9980 Oxoglutarate dehydrogenase E1 component 1.58 1.96E03
Glucose metabolism
Tb927.10.2020 Hexokinase (TbHK2)a 0.43 7.63E03
Tb927.1.3830 Glucose-6-phosphate isomerase 0.58 9.28E05
Tb927.1.3950 Alanine aminotransferase 0.62 4.38E03
TCA cycle and respiration
Tb927.11.9980 Oxoglutarate dehydrogenase E1 component 1.58 1.96E03
Tb927.10.13430 Citrate synthase 10.90 1.18E02
Tb927.10.14000 Aconitase 1.87 1.39E03
Tb927.9.5960 Succinate DH-complex II 1.85 1.55E02
Tb927.8.3380 Succinate DH-complex II 1.88 2.63E03
Tb927.2.4700 Succinate DH-complex II 1.52 1.67E02
Tb927.10.3040 Succinate DH-complex II 1.94 2.09E02
Tb927.10.12540 Complex I subunit 2.76 1.78E02
Tb927.10.13620 Complex I subunit 0.39 6.51E03
Tb927.7.6350 Complex I subunit 5.10 7.17E03
Tb927.11.15820 Complex I subunit 1.95 1.26E02
Tb927.11.6980 Complex I subunit 0.40 1.91E04
Tb927.1.4100 Complex II subunit 1.69 6.97E03
Tb927.9.14200 Complex II subunit 2.86 3.61E02
Tb927.2.3610 Complex V subunita 1.98 2.38E02
Other metabolism-related genes
Tb927.7.3360 Farnesyl pyrophosphate synthase 4.71 6.95E03
Tb11.v5.0178 Glutamine synthetase 4.59 7.32E04
Tb927.8.6170 Transketolasea 2.67 2.71E04
Tb927.3.4850 Mitochondrial enoyl-CoA hydratase 2.37 1.35E02
Tb927.10.3100 Glycerol-3-phosphate acyltransferasea 1.70E06 6.77E03
Tb927.9.4190 Fatty acyl CoA synthetase 1 0.60 7.82E06
Tb927.9.4200 Fatty acyl CoA synthetase 2 0.63 2.70E06
Tb927.9.4210 Fatty acyl CoA synthetase 3 0.39 4.38E04
Tb927.10.14170 Aquaglyceroporin 2 0.46 1.59E05
Tb927.9.6350 Inositol monophosphatasea 5.72E04 3.58E02
Tb927.3.4570 N-Acetylglucosamyl transferase component GPI1 0.01 3.94E02
Tb927.10.4780 GPI inositol deacylase 0.22 4.07E02
Tb927.3.2610 GPI inositol deacylase 2 0.32 1.87E04
Tb927.8.6390 Lysophospholipase 0.62 2.52E02
Tb927.10.6440 Phosphomannomutase 0.67 3.67E02
aArginine methylation identiﬁed in proteome-wide screen (7, 8; unpublished data).
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regulatory mechanisms that play a role in life cycle progression or alternatively may be
a compensatory effect as the cells cope with the stress of ENZ loss.
Having established steady-state levels of proteins in our WT and ENZ KO cell lines,
we proceeded to quantify changes in the mRNA-bound proteome. WT and KO cells
were UV cross-linked, and mRNA was afﬁnity puriﬁed using oligo(dT)-coated magnetic
beads (30). The mRNA with bound proteins was eluted off the beads, and proteins were
quantiﬁed by mass spectrometry (Table S2). We identiﬁed 234 proteins, including 129
out of 155 proteins that were previously identiﬁed as mRNA binding in BF T. brucei by
Lueong et al. (30). We observed signiﬁcant changes in the abundance of 16 proteins
(1.5-fold, P 0.05) in ENZ KO compared to WT parasites (Table 2). Of these, 14
proteins were also identiﬁed in our whole-cell proteome analysis (Table S1). Only the
levels of RBP35 (Tb927.9.12360) and Nopp44/46-2 (Tb927.8.750) signiﬁcantly changed
on the whole-cell level, although eight proteins showed a trend that suggested a
possible change but did not pass the signiﬁcance criteria (Table 2). To verify the
mRNA-bound proteome data set, we repeated the mRNA puriﬁcation experiment in
biological triplicate and detected selected proteins by Western blotting (Fig. 3A). Based
on available antibodies, we chose to assay levels of ZFP3 (Tb927.3.710, unchanged),
NOPP44/46-1 (Tb927.8.760, decreased), and aldolase (Tb927.10.5620, increased). The
aldolase Western blot did not reveal a signiﬁcantly increased association with mRNA in
the ENZ KO cell line, although the quantiﬁcation showed a trend consistent with a
slight increase. This result was not surprising considering that, unlike ZFP3 and
NOPP44/46-1 proteins, which are both involved in nucleic acid metabolism, aldolase is
an extremely abundant metabolic enzyme. Thus, the increased mRNA association of
aldolase in our experiment may be due to contamination of TbPRMT1 KO samples. In
contrast, Western blot analysis conﬁrmed our mass spectrometry results for ZFP3 and
NOPP44/46-1, demonstrating unchanged levels for the former and a decrease of the
latter to less than 30% of WT levels. Interestingly, we previously showed that NOPP44/
46-1 is heavily decorated by ADMA, consistent with an important role for TbPRMT1 in
its activity (7).
Having veriﬁed the data set, we more closely analyzed the proteins exhibiting
altered mRNA association in ENZ-depleted cells. We ﬁrst asked whether these proteins
have commonalities in their subcellular localization by examining data from the
TrypTag project. Interestingly, out of the 8 proteins tagged to date, 7 localize at least
partially to cytoplasmic punctae in PF T. brucei (Tb927.10.4430, Tb927.9.4080,











Tb927.10.5620 6.0 6.E04 1.00 0.84 0.18 Fructose-bisphosphate aldolase, glycosomal
Tb927.10.4430 2.0 3.E02 NA NA 3.3E03 PUF1, posttranscriptional repressor
Tb927.9.10400 1.8 2.E02 0.92 0.11 8.1E03 Nucleolar protein of unknown function
Tb927.10.10280 1.7 1.E02 1.22 1.E02 4.4E02 TbBBP268
Tb927.9.4080 0.6 5.E03 1.13 0.16 2.5E03 Stumpy formation signaling pathway protein
HYP2, posttranscriptional activator
Tb927.6.5010 0.6 8.E03 0.50 0.15 5.3E03 Putative nuclear protein, posttranscriptional repressor
Tb927.9.12360 0.6 3.E03 0.58 6.E03 6.3E03 RBP35, posttranscriptional repressor
Tb927.11.10810 0.5 2.E03 NA NA 8.7E03 PUF11
Tb927.9.15290 0.6 3.E03 0.25 0.42 1.0E02 CHAT domain-containing protein, putative
Tb927.8.710 0.7 1.E02 0.01 0.14 2.3E02 DRBD17
Tb927.10.7310 0.1 2.E04 0.39 0.59 2.7E02 Terminal uridylyltransferase 3
Tb927.8.750 0.6 1.E02 1.90 6.E09 3.3E02 NOPP44/46-2
Tb927.8.760 0.4 8.E03 1.12 0.41 5.0E02 NOPP44/46-1
Tb927.11.4380 0.4 4.E02 0.09 0.15 NA ATP-dependent RNA helicase, putative
Tb927.8.4500 0.5 1.E03 0.36 0.15 3.2E04 eIF4G5, posttranscriptional activator
Tb927.11.14590 0.4 4.E04 0.37 0.16 1.2E02 eIF4G5-interacting protein
aPosttranslational activator/repressor function determined by RNA tethering screen in Erben et al. (53).
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Tb927.9.12360, Tb927.11.10810, Tb927.8.710, Tb927.8.4500, and Tb927.11.14590). We
were also intrigued by the change in mRNA association of eIF4G5, its interacting
protein G5-IP, and two members of the NOPP44/46 family, given the reported
translation-related functions of these proteins. eIF4G5 forms a complex with eIF4E6 and
G5-IP, a protein with similarity to capping enzymes. This complex has afﬁnity for
capped mRNAs, but its depletion does not signiﬁcantly decrease the overall translation
rate (31). NOPP44/46 is a trypanosome-speciﬁc protein family that bears extensive, life
cycle-regulated tyrosine phosphorylation and has been implicated in ribosomal 60S
subunit maturation (32). Since NOPP44/46-1 is known to shuttle between nucleus and
cytoplasm, we ﬁrst wanted to determine whether the decrease in NOPP44/46-1 mRNA
binding could be due to mislocalization (33). We immunolocalized the protein but did
not observe any change between the WT and ENZ KO cell lines (Fig. 3B). Given the
potential roles of the above-mentioned proteins in translation, we next asked whether
ENZ KO leads to an altered translation rate of all or a subset of proteins. We pulsed the
cells with [35S]methionine and separated the nascent proteins by SDS-PAGE. We
detected a reproducible decrease in translation of an50-kDa and an38-kDa protein
but did not see any overall translation defect (Fig. 3C). It is important to note that this
FIG 3 Conﬁrmation of mRNA-bound proteome changes. (A) Western blot conﬁrmation of mRNA-bound
protein levels. (A) (Top) Representative Western blot of indicated proteins. IN, input; EL, elution. Indicated
is % of total sample. Load control, whole-protein Revert staining. (Bottom) Quantiﬁcation of protein
levels. Antibody signals were normalized to Revert and to the mean signal of the WT sample. Mean from
biological triplicates is plotted with error bars denoting standard deviation. P values calculated using
two-tailed t test. **, P 0.005. (B) Immunolocalization of NOPP44/46-1 by immunoﬂuorescence with a
NOPP44/46-1-speciﬁc antibody. Large panel shows merged DAPI and NOPP44/46-1 signal. (C) [35S]me-
thionine labeling of nascent proteins. Labeled cells were lysed, and proteins were separated by
SDS-PAGE. Coomassie, protein load; Radiograph, nascent protein signal. * indicates proteins that
changed expression.
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assay lacks the resolution to visualize low-abundance proteins; therefore, it is quite
possible that the number of proteins whose translation rate is affected exceeds the two
easily visualized proteins. We conclude that the loss of TbPRMT1 alters the mRNA
binding capacity of a small number of cytoplasmic proteins, which in turn may lead to
speciﬁc impacts on mRNA translation.
TbPRMT1 is necessary for an efﬁcient T. brucei starvation stress response. To
begin to distinguish secondary effects of TbPRMT1 depletion from the primary affected
pathways, we need to determine possible TbPRMT1 substrates. Since our antibodies are
not speciﬁc enough to immunoprecipitate either ENZ or PRO subunit, we attempted to
purify exogenously expressed PRO-Myc-His-TAP (PRO-MHT) from BF T. brucei to identify
associated proteins that may be substrates. We were unable to achieve sufﬁcient
expression for proteomic analysis in BF and so switched to PF. We successfully ex-
pressed PRO-MHT and puriﬁed associated proteins (see Table S3 in the supplemental
material). Complexes were eluted by TEV protease cleavage to minimize contaminants,
and cells in which PRO-MHT expression was not induced were used as a negative
control. We reﬁned our data set by eliminating all proteins that were identiﬁed by
2.5 peptides over the negative control, using the replicate with lower peptide count
for that speciﬁc protein. Applying this criterion, we identiﬁed enriched biological
process GO terms for our data set. We observed a signiﬁcant enrichment for proteins
involved in metabolic processes and various levels of gene expression, ﬁndings that
supported our previous data indicating TbPRMT1 involvement in regulation of T. brucei
metabolism (Fig. 4A). Unsurprisingly, when we looked at molecular function GO terms,
FIG 4 Proteins identiﬁed in PRO-MHT puriﬁcation. (A) GO term enrichment was acquired from TriTryp-
db.org. P values are Bonferroni corrected. (B) Venn diagram of proteins present in PRO puriﬁcation and
proteins overrepresented in stress granules (34). P value calculated using R p-hyper function.
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the overwhelming majority of identiﬁed proteins fell into the RNA binding protein
category (Fig. 4A). A single protein was identiﬁed in common between the proteins that
changed their mRNA association and proteins that copurify with TbPRMT1: a nucleolar
protein with unknown function (Tb927.9.10400). Although not identiﬁed as methylated
on arginine residues in our proteome-wide screen (7, 8; also unpublished data), the
Tb927.9.10400 sequence contains multiple RGG motif repeats, which are typically
targeted by arginine methylation, making Tb927.9.10400 a promising target for future
studies. One ﬁnding that caught our eye was the signiﬁcant overlap of proteins that
copurify with TbPRMT1 and proteins that are enriched in T. brucei starvation granules
(34) (Fig. 4B) (P 5.3 108) (Table 3). This includes SCD6 (Tb927.11.550), a stress-
related protein that was previously reported to copurify with TbPRMT1 (35). Association
of TbPRMT1 with starvation stress-related granules was particularly striking since the
PRO subunit of TbPRMT1 itself was enriched in a recent proteomic analysis of stress
granules (34). To investigate a possible role of TbPRMT1 in stress granule formation, we
utilized a PF ENZ RNAi cell line that efﬁciently ablates PRO and ENZ protein levels when
induced by doxycycline (11). Either uninduced or RNAi-induced cells were starved by a
two-hour incubation in PBS, and mRNA was subsequently visualized by oligo(dT)
ﬂuorescent in situ hybridization (FISH) (Fig. 5A). We classiﬁed the cells as either stressed
(clearly containing RNA granules), intermediate (some granulation might be present), or
normal (mRNA distributed evenly throughout cytoplasm) (Fig. 5B, lower panel). We
observed a statistically signiﬁcant decrease in cells that were able to form stress
granules upon TbPRMT1 depletion (Fig. 5B, upper panel). Together, these data dem-
onstrate a role for TbPRMT1 in starvation stress granule formation in PF T. brucei and
suggest potential substrates that may contribute to this effect.
TbPRMT1 directly binds to nucleic acid. The effect of TbPRMT1 on stress granule
formation led us to investigate the possibility that TbPRMT1 might itself be able to
associate with RNA. This notion was supported by a recently reported mRNA-bound
proteome study in which more PRO peptides were puriﬁed with the mRNA than in the
negative control, although the signiﬁcance criterion was not met (30). To investigate
whether TbPRMT1 has RNA binding properties, we began by analyzing the association
of TbPRMT1 with mRNA in vivo. We attempted to use our antipeptide TbPRMT1
antibodies; however, the results were inconclusive due to the interference of nonspe-
ciﬁc bands (data not shown). Therefore, we utilized our PRO-MHT cell line to purify the




Product name R methylationRep1 Rep2 Neg ctrl
Tb927.10.3560 501 622 PRO
Tb927.1.4690 216 274 ENZ
Tb927.9.12510 20 35 5 ATP-dependent DEAD/H RNA helicase ADMA/DMA/MMA
Tb927.11.550 20 31 8 Hypothetical protein SCD6.10
Tb927.10.2370 19 15 Lupus La protein homolog
Tb927.4.2040 15 15 DNA/RNA-binding protein Alba 3 DMA/MMA
Tb927.9.13990 14 17 RNA-binding protein, putative
Tb927.11.14220 12 17 3 Hypothetical protein, conserved
Tb927.10.6060 11 9 Universal minicircle sequence binding protein 2
Tb927.11.2250 6 24 HYP11 ADMA
Tb927.10.6050 6 16 Clathrin heavy chain
Tb927.10.11760 5 8 Pumilio/PUF RNA binding protein 6 ADMA
Tb927.7.4900 4 7 5=–3= exoribonuclease A SDMA/MMA
Tb927.6.640 4 6 ApaH-like phosphatase ALPH1
Tb927.8.990 3 8 RNA-binding protein 33 ADMA/SDMA
Tb927.10.14950 3 7 Zinc ﬁnger CCCH domain-containing protein 40
Tb927.6.1870 3 5 Eukaryotic translation initiation factor 4E-4
Tb927.4.410 2 5 CAF 40
Tb927.8.1500 2 3 Hypothetical protein, conserved
aDMA, dimethylarginine (ADMA/SDMA could not be determined); ADMA, asymmetric dimethylarginine; SDMA, symmetric dimethylarginine; MMA,
monomethylarginine.
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mRNA-bound proteins. Due to the presence of the protein A moiety in the TAP tag, the
secondary anti-rabbit IgG antibody strongly recognized the tagged protein (Fig. 6). We
saw a clear association of PRO-MHT with mRNA as well as the presence of our positive
control, DRBD18. Our negative control, p22, was not present in the ﬁnal eluate.
Therefore, we conclude that PRO associates with mRNA in vivo. To conﬁrm that PRO
FIG 5 TbPRMT1 is necessary for mRNA migration to starvation stress granules. (A) mRNA was visualized
by oligo(dT) FISH in the PF ENZ RNAi cell line. Uninduced cells (dox-) or RNAi-induced cells (dox) were
either cultured in medium (Normal) or nutritionally starved (Stress). mRNA was visualized by FISH (red),
and DNA was stained with DAPI (blue). (B) Cells were divided into normal (N), intermediate (I), or granule
(G) categories (for examples, see bottom panel) and counted. Means for two biological replicates of 300
to 500 cells each were plotted, and P values were calculated using the chi-squared test. ***, P 0.0005.
Error bars show the range of values from each experiment.
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directly associates with RNA, we turned to in vitro methods. Since our attempts to
identify in vivo TbPRMT1 mRNA targets were unsuccessful, we utilized a 102-nt 32P-
labeled pBluescript SK plasmid RNA. We generated recombinant TbPRMT1 heterote-
tramer by ENZ and His-PRO coexpression in Escherichia coli followed by nickel afﬁnity
puriﬁcation of the complex as described previously (12). Individual TbPRMT1 subunits
were expressed as His-ENZ or His-PRO separately and puriﬁed. We incubated the RNA
with TbPRMT1, individual TbPRMT1 subunits, and other T. brucei PRMTs; UV cross-linked
the samples; separated them by SDS-PAGE; and visualized RNA-bound complexes
(Fig. 7A). We observed no RNA binding when only the ENZ TbPRMT1 subunit was
present, although this result should be viewed with caution, since the ENZ subunit is
difﬁcult to purify by itself and is prone to aggregation. Importantly, we saw clear RNA
binding of the PRO subunit both incubated alone with RNA and within the context of
the entire TbPRMT1 heterotetramer. We also observed binding of TbPRMT7, a type III
PRMT that was enriched in the published T. brucei mRNA-bound proteome to a similar
degree as TbPRMT1 (30). TbPRMT6 was not found cross-linked to RNA, suggesting that
in vitro RNA binding is not a default feature of all PRMTs. Next, we wanted to utilize
another, more native method to conﬁrm that TbPRMT1 binds RNA in vitro. We incu-
bated increasing concentrations of TbPRMT1 or its PRO subunit with labeled RNA and
resolved the reaction mixtures by native PAGE, resulting in an electrophoretic mobility
shift (EMSA) of protein-bound RNA. We saw a distinct shift of RNA migration at the
highest protein concentrations (2 and 4 M) (Fig. 7B). This suggests a relatively low
afﬁnity of TbPRMT1 for pBluescript RNA but conﬁrms TbPRMT1 RNA binding ability.
Some proteins exhibit afﬁnity for speciﬁc polynucleotide sequences, and the in vivo
mRNA binding activity of TbPRMT1 suggested it could exhibit high afﬁnity for poly(A).
To investigate whether TbPRMT1 has a preference for speciﬁc polynucleotides, we
performed the in vitro RNA cross-linking assay using a 47-nt transcript of pBluescript
sequence in the presence of increasing amounts of unlabeled poly(A), poly(C), poly(U),
and poly(G) to determine their abilities to compete with the labeled probe for binding
to TbPRMT1 (Fig. 7C). In these assays, PRO exhibited a preference for poly(U) and
poly(G) but little binding to poly(A) or poly(C). Considering the low afﬁnity of TbPRMT1
for RNA, we wanted to determine whether TbPRMT1 binds RNA speciﬁcally or whether
the binding ability extends to all nucleic acids. We incubated TbPRMT1 with labeled
RNA in the presence of unlabeled RNA or DNA competitor. We saw that the two
competitors performed equally; therefore, we conclude that TbPRMT1 has nucleic acid
binding ability (Fig. 7D). In another study (H. Hashimoto, L. Kafková, K. Jordan, L. K.
Read, and E. W. Debler, submitted for publication), we determined that TbPRMT1
tetramerization is necessary for TbPRMT1 methylation activity. We thus wanted to test
whether the tetramerization also inﬂuences TbPRMT1 RNA binding properties. We
performed the RNA cross-linking assay on a battery of mutants that were unable to
tetramerize (Fig. 7E). We observed that while tetramerization is not required for RNA
binding, speciﬁc mutations in either the ENZ or PRO subunits of TbPRMT1 decrease the
FIG 6 TbPRMT1 binds mRNA in vivo. mRNA was puriﬁed from PF cells expressing PRO-MHT, which were
either left untreated (UV X-link -) or UV cross-linked (UV X-link) prior to lysis. Western blotting was used
to detect the indicated proteins in input (IN), oligo(dT) bead ﬂowthrough (FT), and oligo(dT) bead elution
(EL). Percentages loaded are indicated. Positive control, DRBD18; negative control, p22. Arrows indicate
migration of target proteins.
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RNA binding potential of the protein complex. The ﬁnding that speciﬁc mutations are
able to decrease TbPRMT1 RNA afﬁnity strongly suggests that TbPRMT1 RNA binding is
a speciﬁc and biologically relevant property of the enzyme, and it opens a window to
further studies that will determine the residues directly involved in TbPRMT1 RNA
binding.
DISCUSSION
Arginine methylation is a ubiquitous posttranslational modiﬁcation that inﬂuences
a broad spectrum of eukaryotic cellular processes (36–41). The enzymes catalyzing this
modiﬁcation, PRMTs, are astonishingly well conserved throughout the eukaryotic king-
dom. The enzymatic subunit of TbPRMT1, for example, shares 53% amino acid se-
quence identity with human PRMT1, a homology quite unusual between organisms
with such evolutionary distance between them. In this study, we provide biochemical
FIG 7 TbPRMT1 binds mRNA in vitro. (A) 32P-labeled pBluescript SK RNA was cross-linked to equimolar
amounts of the indicated recombinant proteins. PRMT molarity was calculated per dimer. Reaction
mixtures were treated with RNase A and resolved by SDS-PAGE. The dried, Coomassie blue-stained gel
was exposed to a phosphorimager screen (Radiograph). Positive control, MBP-MRB8180; negative
control, His-p22. (B) 32P-labeled pBluescript SK RNA was incubated with increasing amounts of
recombinant TbPRMT1 or PRO. Reaction mixtures were resolved by native PAGE, and the dried gel was
visualized by phosphorimager screen exposure. #, free RNA; *, PRMT/RNA complex; , possible PRMT/
RNA aggregate. (C) UV cross-linking assay performed as in panel A in the presence of unlabeled oligo(N)
competitor. (D) UV cross-linking assay performed as in panel A in the presence of unlabeled RNA/DNA
competitor. (E) UV cross-linking assay performed as in panel A utilizing a battery of TbPRMT1 mutants.
Table at bottom of panel E describes the mutations. P or E in the superscript designates whether the
mutation was in the PRO or ENZ subunit, respectively.
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and cell biological characterization of TbPRMT1. We show that in BF T. brucei, TbPRMT1
promotes virulence in the animal model, inﬂuences energy metabolism, and changes
mRNA association of a small subset of proteins. In insect-stage parasites, loss of
TbPRMT1 signiﬁcantly hinders the parasite’s ability to form mRNA-containing cytoplas-
mic granules as a response to starvation stress. Furthermore, we show that TbPRMT1 is
itself able to bind nucleic acids both in vitro and in vivo.
The virulence decrease of ENZ KO trypanosomes is interesting in the context of a
phenotype observed in Leishmania major, a parasite closely related to Trypanosoma
species. In contrast to what we observed in TbPRMT1 KO parasites, deletion of the
LmjPRMT7 gene led to an increase in virulence, while overexpression caused decreased
lesion progression in a mouse model (42). PRMTs are well known to engage in interplay
in both T. brucei and human cells (11, 21). Depletion of PRMT1 in both cell types causes
a massive increase in MMA, which in T. brucei PF cells is attributed to TbPRMT7 activity
(11). While the opposing effects of downregulating the two proteins could be a
coincidence, especially considering that the data originated from different species, it is
plausible that the virulence decrease we observe in the absence of TbPRMT1 results
from increased TbPRMT7 activity.
Trypanosomes extensively modulate their energy metabolism throughout their life
cycle as well as in response to available nutrients (43, 44). In ENZ KO cells, we observed
a number of alterations in metabolic enzyme abundance that are reminiscent of
metabolic changes observed during T. brucei life cycle progression, namely, a decrease
in glycolytic enzymes and an increase in components of the citric acid cycle and the
proline degradation pathway. This prompted us to assess the ability of ENZ KO cells to
undergo citrate-/cis-aconitate-induced in vitro differentiation from BF to PF. We did not
observe any difference in the rate at which the cells acquired a procyclin coat or lost
VSG coating compared to WT parasites (data not shown). This result could suggest that
the observed changes are a result of slow growth rather than a reﬂection of interfer-
ence with life cycle progression regulation (45, 46). However, it is important to note that
the citrate/cis-aconitate differentiation method forces the parasites to progress from BF
to PF, skipping the stumpy stage, which our laboratory strain is not able to produce.
Both the observed 50% decrease in mRNA binding of HYP2 (Tb927.9.4080), a protein
identiﬁed in a screen aimed at factors driving stumpy formation, and the increase in
PAD2 protein levels in ENZ KO cells suggest possible TbPRMT1 involvement in BF to
stumpy-stage progression (4). Furthermore, the observed defect in starvation granule
formation in TbPRMT1-depleted cells hints at a possible defect in a life cycle progres-
sion through impaired response to the nutrient-poor environment that is naturally
found in ﬂy midgut and salivary glands. It is known that the differentiation of Trypano-
soma cruzi, a close relative of T. brucei, from proliferative epimastigotes to infective
growth-arrested metacyclic trypomastigotes requires nutritional stress as one of the
signals (47, 48). To better understand the role of TbPRMT1 in the life cycle progression
of T. brucei, it will be necessary to generate a pleomorphic T. brucei cell line lacking
TbPRMT1 and observe the ability of these cells to progress through the natural life cycle
in the animal and ﬂy hosts.
To begin understanding the direct effects of TbPRMT1-mediated methylation, it is
important to identify TbPRMT1 substrates. Some of the observed effects are likely
caused by regulation of RNA binding proteins either by direct methylation or by
methylation of their binding partners. Our data show changes in the mRNA association
of several RNA binding proteins. PUF1 and Tb927.9.10400 exhibit increased association
with RNA in the absence of TbPRMT1. PUF1 depletion causes only minor changes in PF
and BF gene expression, although this was investigated only by the relatively insensi-
tive microarray approach, and the role of PUF1 in other T. brucei life cycle stages was
not investigated (49). PUF1 is unlikely to be a direct target of TbPRMT1, since our
proteome-wide screens did not identify arginine methylation of PUF1, nor was PUF1
found associated with TbPRMT1 (7, 8; unpublished data). Tb927.9.10400 is a nucleolar
protein of unknown function (50). Despite the absence of Tb927.9.10400 in our
proteome-wide methylation screen, the protein sequence contains numerous RGG
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repeats that are typically targeted by arginine methylation. Furthermore, Tb927.9.10400
was in the top 5% of PRO-MHT-interacting proteins based on the spectral count,
making it a promising candidate for future studies.
None of the proteins that decreased their mRNA association upon ENZ KO were
found interacting with TbPRMT1. Nevertheless, the decrease in HYP2 mRNA binding
that we observed in ENZ KO cells is intriguing. HYP2 contains a DksA zinc ﬁnger, a motif
involved in nutritional status and quorum sensing responses in prokaryotes, and has
been identiﬁed as a part of a quorum sensing signaling cascade that plays a role in
stumpy-stage formation in T. brucei (4). The HYP2 protein sequence contains a number
of arginines in the RG context, making it a potential target of arginine methylation. It
is also possible that the HYP2-mRNA interaction is indirectly affected by TbPRMT1
activity. HYP11 (Tb927.11.2250) was also implicated to play a role in stumpy formation
(4, 51). HYP11 bears an ADMA mark, copuriﬁes with TbPRMT1, has RNA binding
properties, and is enriched in stress granules (4, 30, 34), strongly suggesting that HYP11
is a primary TbPRMT1 target. While HYP11 mRNA binding is not changed in our screen,
it is possible that arginine methylation of HYP11 inﬂuences HYP2 mRNA binding or
changes the composition of an HYP11-containing ribonucleoprotein, ultimately altering
mRNA fate. It is important to note that our mRNA binding screen is likely biased toward
identiﬁcation of mRNA association changes in proteins with a narrow speciﬁcity toward
a small subset of mRNAs, since changes in speciﬁcity of proteins with a large pool of
bound mRNAs would not result in a statistically signiﬁcant change in overall mRNA
binding.
Other regulators of mRNA fate that could be affected by arginine methylation
include DRBD3 and SCD6. DRBD3 is essential in PF cells and acts as a stabilizing factor
of a small subset of mRNAs, some of which undergo stage-speciﬁc regulation (52).
Considering that levels of DRBD3 remain constant between PF and BF cells, it is possible
that stage-speciﬁc regulation is achieved through PTM decoration (52). Interestingly,
among DRBD3 targets are the enzymes constituting the proline degradation pathway,
several of which are upregulated in ENZ KO cells. DRBD3 was annotated as a posttran-
scriptional activator based on a high-throughput tethering assay (53). DRBD3 was not
found methylated in our screen; however, it does harbor an RGG motif that is typically
targeted by PRMTs. Starvation stress alters the composition of DRBD3-associated
ribonucleoprotein complexes and causes DRBD3 to localize into cytoplasmic granules
(54). Among DRBD3-interacting proteins are PABP1, PABP2, and NOT1, all of which
copurify with TbPRMT1 and are also overrepresented in starvation stress granules (54).
It is plausible that DRBD3 function is regulated through methylation of these proteins.
Furthermore, DRBD3 appears as a possible mechanistic link between stage-speciﬁc
metabolism regulation and starvation stress response. SCD6/RAP55 is a translational
repressor with a function in stress granule formation in yeast and mammals (55–57).
SCD6 function is modulated by HMT1/PRMT1 in yeast and mammals, and in T. brucei
SCD6 strongly interacts with TbPRMT1 and is methylated on three arginine residues (35,
58–61). Unlike SCD6 in other organisms, TbSCD6 does not seem to be necessary for
formation of mRNA-containing granules under starvation conditions (35). However,
TbSCD6 is a component of processing bodies, which are constitutive components of
cytoplasmic mRNA metabolism in trypanosomes with a putative role in translational
repression (62). The tight association of TbSCD6 with TbPRMT1 suggests that TbSCD6 is
likely to play a role in some of the changes we observe on the proteome level.
TbPRMT1 could also be involved in directly regulating the functions of metabolic
enzymes in the affected pathways. Glycolysis is the main pathway that provides energy
for BF T. brucei cells (63). Upon knockout of ENZ, we see approximately a 50% decrease
in hexokinase 2 (TbHK2) and phosphoglucose isomerase levels. We also noted a 40%
decrease in levels of alanine aminotransferase, an enzyme responsible for conversion of
pyruvate to alanine, a pathway that is extensively utilized in BF trypanosomes (26).
Together, these data suggest a decrease in glycolytic ﬂux, and direct measurement of
the impact of TbPRMT1 knockout on the glycolytic rate is a future focus. Hexokinase
catalyzes a virtually irreversible reaction that commits glucose to glycolysis. T. brucei
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carries two genes with hexokinase homology that are 98% identical at the amino acid
level, TbHK1 and TbHK2. Unlike in other eukaryotes where hexokinases function as
dimers, TbHKs form hexameric complexes, and they were isolated from cells as a
heterohexamer containing an unknown ratio of TbHK1 and TbHK2 (64). T. brucei further
differs from mammals in that TbHK is not inhibited by its product, glucose-6-phosphate
(65). While TbHK2 is not active on its own, it gains activity when complexed with
inactive TbHK1 (66). This complex then becomes amenable to inhibition by pyrophos-
phate, a molecule that has no effect on the TbHK1 homohexamer (66). These ﬁndings
suggest that the two enzymes have distinct regulatory mechanisms that differ from the
mammalian hexokinase regulation system. A peptide that could originate from either
TbHK1 or TbHK2 (SKYRFVLPTTKFDLD) was shown to bear arginine dimethylation in our
proteome-wide screen; therefore, TbPRMT1 is likely to contribute to this intricate and
unusual pathway for regulation of glycolysis.
We show here that TbPRMT1 has nucleic acid binding properties and associates with
mRNA in vivo. Future studies will be focused on determining the functional relevance
of this property. One possibility is that TbPRMT1 can methylate RNA as well as arginines.
TbPRMT1 shares features with the human RNA methyltransferase Mettl3/Mettl14.
Mettl3/14 form a heterodimer in which Mettl3 is a catalytically active subunit while
Mettl14 plays a critical structural role necessary for substrate recognition (67). Once in
vivo RNA targets of TbPRMT1 are identiﬁed, they can be tested as potential substrates.
Another possibility is that RNA binding plays a role in deﬁning the appropriate
topology of TbPRMT1 in respect to RNA-/DNA-bound substrates, as in the case of
human lysine SET1 methyltransferase (68). Indeed, nucleic acid binding may be a
conserved property of PRMT1 enzymes rather than a feature speciﬁc to T. brucei. PRMT1
was identiﬁed among the mRNA-associated proteins in two independent mRNA-bound
proteome studies using human hepatocytic HuH-7 cells and human embryonic kidney
HEK293 cells (69, 70). Interestingly, human PRMT1 localizes to cytoplasmic granules
upon arsenite treatment, suggesting further similarities between the two enzymes (71).
Neither TbPRMT1 nor HsPRMT1 contains a known RNA binding domain. We identiﬁed
speciﬁc residues in TbPRMT1 that, when mutated, attenuate its RNA binding activity,
suggesting it may be possible to create a nucleic-acid-binding-deﬁcient mutant that
could in turn be used to further probe the biological signiﬁcance of this feature.
In summary, we demonstrate here that TbPRMT1 affects T. brucei virulence, metab-
olism, and ability to cope with starvation stress. We identiﬁed a subset of proteins that
change their mRNA association upon TbPRMT1 depletion, providing new directions for
examining the role played by arginine methylation in regulation of RNA binding
proteins. Furthermore, we established that TbPRMT1 itself has the ability to associate
with nucleic acids, a ﬁnding that may have more widespread implications among
PRMT1 homologs. We identiﬁed candidate TbPRMT1 targets that play a role in a broad
spectrum of processes, extending the impact of this work to numerous ﬁelds of study,
such as life cycle progression, translation, stress response, and metabolism regulation.
Future studies will be aimed at distinguishing primary effects of TbPRMT1 loss from
downstream proteome changes and deciphering the role that nucleic acid binding
plays in TbPRMT1’s mechanism of action.
MATERIALS AND METHODS
For details including buffer compositions and antibody sources, please refer to Text S1 in the
supplemental material.
T. brucei cell culture and cell lines. PF T. brucei strain 29-13 and all cell lines derived from this strain
were grown in SM medium supplemented with 10% FBS. The BF SM427 strain was cultured in HMI-11
medium supplemented with 10% FBS. The ENZ KO cell line was created by replacing both ENZ alleles
with drug resistance markers. The PRO-MHT cell line contains a tetracycline-inducible C-terminally
Myc-His-TAP-tagged PRO construct derived from pLEW100. The PRO-mNG-TY cell line was created using
pPOTv6-mNG according to the published protocol (72). The ENZ RNAi cell line was created as described
in reference 11.
Statistical analysis. Statistical signiﬁcance of doubling time differences was calculated using
multiple-comparison one-way ANOVA (Fig. 1). Western blot differences were tested by Student’s t test
(Fig. 2 and 3). GO term enrichment P values were calculated by Fisher’s exact test with Bonferroni
correction (Fig. 4A). P value of overlap of two protein data sets was determined by R p-hyper function
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(Fig. 4B). Signiﬁcance of differences between amounts of granule-containing cells in uninduced and
induced ENZ RNAi cell lines was determined by the chi-square test (Fig. 5). For proteomics data sets,
statistical signiﬁcance between groups was evaluated using a Student t test (Table S1 and S2).
Mouse infection assay. Fourteen female CD-1 mice (10 to 12 weeks; Charles River) were infected by
intraperitoneal injection with 1 105 bloodstream-form T. brucei parasites; half were TbPRMT1 ENZ
knockout (ENZ KO; n  7) or SM parental strain (WT; n  7). The course of infection was monitored, and
time to death was recorded. Experiments were carried out in accordance with protocols approved by the
Institutional Animal Care and Use Committee (IACUC) of Clemson University.
Whole-cell proteome and mRNA-bound proteome. Approximately 4 106 cells were harvested,
and whole-cell proteomes were quantiﬁed as described in Text S1. mRNA-bound proteome puriﬁcation
was performed as described previously, with only minor modiﬁcations (30). The protein description in
Table 2 includes posttranscriptional activator/repressor annotation that was established by a genome-
wide tethering screen (53).
Immunolocalization and ﬂuorescence in situ hybridization. NOPP44/46-1 was immunolocalized
using antibody against the protein (1:2,000 dilution). FISH was performed using an oligo(dT) probe fused
to Alexa Fluor 488 in an overnight (O/N) hybridization protocol.
In vitro RNA binding, competition, and EMSA. A 102-nt RNA fragment of pBluescript SK plasmid
sequence was in vitro transcribed. A UV-cross-linking-based RNA binding assay was performed as
described previously with minor modiﬁcations (73). PRMT molarity was determined per dimer in all cases.
Afﬁnity for different polynucleotides was determined by adding a mass excess of polynucleotide into the
reaction mixture prior to the addition of the protein. To perform EMSA, a 47-nt RNA fragment of the
pBluescript SK plasmid was transcribed and incubated with a recombinant protein. Reaction mixtures
were resolved on native PAGE.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.02430-18.
TEXT S1, DOCX ﬁle, 0.05 MB.
FIG S1, PDF ﬁle, 0.3 MB.
TABLE S1, XLSX ﬁle, 1.3 MB.
TABLE S2, XLSX ﬁle, 0.1 MB.
TABLE S3, XLSX ﬁle, 5.3 MB.
TABLE S4, XLSX ﬁle, 0.01 MB.
ACKNOWLEDGMENTS
This work was supported by National Institutes of Health grants R01 AI060260 and
R21 AI125746 to L.K.R. and P20 GM109094 to K.S.P. and American Heart Association
predoctoral fellowship 15PRE24480155 to L.K.
We thank Noreen Williams, Joseph Shlomai, Meredith Morris, and Keith Matthews for
donation of antibodies. We acknowledge Jay Bangs and Calvin Tiengwe for consulta-
tion and help with ﬂuorescent microscopy.
REFERENCES
1. Keating J, Yukich JO, Sutherland CS, Woods G, Tediosi F. 2015. Human
African trypanosomiasis prevention, treatment and control costs: a
systematic review. Acta Trop 150:4–13. https://doi.org/10.1016/j
.actatropica.2015.06.003.
2. Shaw AP, Cecchi G, Wint GR, Mattioli RC, Robinson TP. 2014. Mapping
the economic beneﬁts to livestock keepers from intervening against
bovine trypanosomosis in Eastern Africa. Prev Vet Med 113:197–210.
https://doi.org/10.1016/j.prevetmed.2013.10.024.
3. Bakker BM, Westerhoff HV, Michels PA. 1995. Regulation and control of
compartmentalized glycolysis in bloodstream form Trypanosoma brucei.
J Bioenerg Biomembr 27:513–525. https://doi.org/10.1007/BF02110191.
4. Mony BM, MacGregor P, Ivens A, Rojas F, Cowton A, Young J, Horn D,
Matthews K. 2014. Genome-wide dissection of the quorum sensing
signalling pathway in Trypanosoma brucei. Nature 505:681–685. https://
doi.org/10.1038/nature12864.
5. Mantilla BS, Marchese L, Casas-Sanchez A, Dyer NA, Ejeh N, Biran M,
Bringaud F, Lehane MJ, Acosta-Serrano A, Silber AM. 2017. Proline
metabolism is essential for Trypanosoma brucei brucei survival in the
tsetse vector. PLoS Pathog 13:e1006158. https://doi.org/10.1371/journal
.ppat.1006158.
6. Michaeli S. 2011. Trans-splicing in trypanosomes: machinery and its
impact on the parasite transcriptome. Future Microbiol 6:459–474.
https://doi.org/10.2217/fmb.11.20.
7. Lott K, Li J, Fisk JC, Wang H, Aletta JM, Qu J, Read LK. 2013. Global
proteomic analysis in trypanosomes reveals unique proteins and con-
served cellular processes impacted by arginine methylation. J Proteom-
ics 91:210–225. https://doi.org/10.1016/j.jprot.2013.07.010.
8. Fisk JC, Li J, Wang H, Aletta JM, Qu J, Read LK. 2013. Proteomic analysis
reveals diverse classes of arginine methylproteins in mitochondria of
trypanosomes. Mol Cell Proteomics 12:302–311. https://doi.org/10.1074/
mcp.M112.022533.
9. Larsen SC, Sylvestersen KB, Mund A, Lyon D, Mullari M, Madsen MV,
Daniel JA, Jensen LJ, Nielsen ML. 2016. Proteome-wide analysis of argi-
nine monomethylation reveals widespread occurrence in human cells.
Sci Signal 9:rs9. https://doi.org/10.1126/scisignal.aaf7329.
10. Bedford MT. 2007. Arginine methylation at a glance. J Cell Sci 120:
4243–4246. https://doi.org/10.1242/jcs.019885.
11. Lott K, Zhu L, Fisk JC, Tomasello DL, Read LK. 2014. Functional interplay
between protein arginine methyltransferases in Trypanosoma brucei.
Microbiologyopen 3:595–609. https://doi.org/10.1002/mbo3.191.
12. Pelletier M, Pasternack DA, Read LK. 2005. In vitro and in vivo analysis of
the major type I protein arginine methyltransferase from Trypanosoma
TbPRMT1 Inﬂuences Metabolism and Stress Response ®
November/December 2018 Volume 9 Issue 6 e02430-18 mbio.asm.org 17
 o
n








brucei. Mol Biochem Parasitol 144:206–217. https://doi.org/10.1016/j
.molbiopara.2005.08.015.
13. Kafková L, Debler EW, Fisk JC, Jain K, Clarke SG, Read LK. 2017. The major
protein arginine methyltransferase in Trypanosoma brucei functions as
an enzyme-prozyme complex. J Biol Chem 292:2089–2100. https://doi
.org/10.1074/jbc.M116.757112.
14. Goulah CC, Read LK. 2007. Differential effects of arginine methylation on
RBP16 mRNA binding, guide RNA (gRNA) binding, and gRNA-containing
ribonucleoprotein complex (gRNP) formation. J Biol Chem 282:
7181–7190. https://doi.org/10.1074/jbc.M609485200.
15. Goulah CC, Pelletier M, Read LK. 2006. Arginine methylation regulates
mitochondrial gene expression in Trypanosoma brucei through multiple
effector proteins. RNA 12:1545–1555. https://doi.org/10.1261/rna.90106.
16. Lott K, Mukhopadhyay S, Li J, Wang J, Yao J, Sun Y, Qu J, Read LK. 2015.
Arginine methylation of DRBD18 differentially impacts its opposing
effects on the trypanosome transcriptome. Nucleic Acids Res 43:
5501–5523. https://doi.org/10.1093/nar/gkv428.
17. Lee WC, Lin WL, Matsui T, Chen ES, Wei TY, Lin WH, Hu H, Zheng YG, Tsai
MD, Ho MC. 2015. Protein arginine methyltransferase 8: tetrameric
structure and protein substrate speciﬁcity. Biochemistry 54:7514–7523.
https://doi.org/10.1021/acs.biochem.5b00995.
18. Toma-Fukai S, Kim JD, Park KE, Kuwabara N, Shimizu N, Krayukhina E,
Uchiyama S, Fukamizu A, Shimizu T. 2016. Novel helical assembly in
arginine methyltransferase 8. J Mol Biol 428:1197–1208. https://doi.org/
10.1016/j.jmb.2016.02.007.
19. Zhang X, Cheng X. 2003. Structure of the predominant protein arginine
methyltransferase PRMT1 and analysis of its binding to substrate pep-
tides. Structure 11:509–520. https://doi.org/10.1016/S0969-2126(03)
00071-6.
20. Tang J, Gary JD, Clarke S, Herschman HR. 1998. PRMT 3, a type I protein
arginine N-methyltransferase that differs from PRMT1 in its oligomeriza-
tion, subcellular localization, substrate speciﬁcity, and regulation. J Biol
Chem 273:16935–16945. https://doi.org/10.1074/jbc.273.27.16935.
21. Dhar S, Vemulapalli V, Patananan AN, Huang GL, Di Lorenzo A, Richard
S, Comb MJ, Guo A, Clarke SG, Bedford MT. 2013. Loss of the major type
I arginine methyltransferase PRMT1 causes substrate scavenging by
other PRMTs. Sci Rep 3:1311. https://doi.org/10.1038/srep01311.
22. Yu MC. 2011. The role of protein arginine methylation in mRNP dynam-
ics. Mol Biol Int 2011:163827. https://doi.org/10.4061/2011/163827.
23. Rho J, Choi S, Jung CR, Im DS. 2007. Arginine methylation of Sam68 and
SLM proteins negatively regulates their poly(U) RNA binding activity.
Arch Biochem Biophys 466:49–57. https://doi.org/10.1016/j.abb.2007.07
.017.
24. Cui W, Yoneda R, Ueda N, Kurokawa R. 2018. Arginine methylation of
translocated in liposarcoma (TLS) inhibits its binding to long noncoding
RNA, abrogating TLS-mediated repression of CBP/p300 activity. J Biol
Chem 293:10937–10948. https://doi.org/10.1074/jbc.RA117.000598.
25. Das A, Bellofatto V, Rosenfeld J, Carrington M, Romero-Zaliz R, del Val C,
Estévez AM. 2015. High throughput sequencing analysis of Trypano-
soma brucei DRBD3/PTB1-bound mRNAs. Mol Biochem Parasitol 199:
1–4. https://doi.org/10.1016/j.molbiopara.2015.02.003.
26. Creek DJ, Mazet M, Achcar F, Anderson J, Kim DH, Kamour R, Morand P,
Millerioux Y, Biran M, Kerkhoven EJ, Chokkathukalam A, Weidt SK, Bur-
gess KE, Breitling R, Watson DG, Bringaud F, Barrett MP. 2015. Probing
the metabolic network in bloodstream-form Trypanosoma brucei using
untargeted metabolomics with stable isotope labelled glucose. PLoS
Pathog 11:e1004689. https://doi.org/10.1371/journal.ppat.1004689.
27. Baker N, Glover L, Munday JC, Aguinaga Andres D, Barrett MP, de Koning
HP, Horn D. 2012. Aquaglyceroporin 2 controls susceptibility to melar-
soprol and pentamidine in African trypanosomes. Proc Natl Acad Sci
U S A 109:10996–11001. https://doi.org/10.1073/pnas.1202885109.
28. Urbaniak MD, Guther ML, Ferguson MA. 2012. Comparative SILAC pro-
teomic analysis of Trypanosoma brucei bloodstream and procyclic life-
cycle stages. PLoS One 7:e36619. https://doi.org/10.1371/journal.pone
.0036619.
29. Dean S, Marchetti R, Kirk K, Matthews KR. 2009. A surface transporter
family conveys the trypanosome differentiation signal. Nature 459:
213–217. https://doi.org/10.1038/nature07997.
30. Lueong S, Merce C, Fischer B, Hoheisel JD, Erben ED. 2016. Gene
expression regulatory networks in Trypanosoma brucei: insights into the
role of the mRNA-binding proteome. Mol Microbiol 100:457–471.
https://doi.org/10.1111/mmi.13328.
31. Freire ER, Malvezzi AM, Vashisht AA, Zuberek J, Saada EA, Langousis G,
Nascimento JD, Moura D, Darzynkiewicz E, Hill K, de Melo Neto OP,
Wohlschlegel JA, Sturm NR, Campbell DA. 2014. Trypanosoma brucei
translation initiation factor homolog EIF4E6 forms a tripartite cytosolic
complex with EIF4G5 and a capping enzyme homolog. Eukaryot Cell
13:896–908. https://doi.org/10.1128/EC.00071-14.
32. Jensen BC, Brekken DL, Randall AC, Kifer CT, Parsons M. 2005. Species
speciﬁcity in ribosome biogenesis: a nonconserved phosphoprotein is
required for formation of the large ribosomal subunit in Trypanosoma
brucei. Eukaryot Cell 4:30–35. https://doi.org/10.1128/EC.4.1.30-35.2005.
33. Hellman K, Prohaska K, Williams N. 2007. Trypanosoma brucei RNA
binding proteins p34 and p37 mediate NOPP44/46 cellular localization
via the exportin 1 nuclear export pathway. Eukaryot Cell 6:2206–2213.
https://doi.org/10.1128/EC.00176-07.
34. Fritz M, Vanselow J, Sauer N, Lamer S, Goos C, Siegel TN, Subota I,
Schlosser A, Carrington M, Kramer S. 2015. Novel insights into RNP
granules by employing the trypanosome’s microtubule skeleton as a
molecular sieve. Nucleic Acids Res 43:8013–8032. https://doi.org/10
.1093/nar/gkv731.
35. Cristodero M, Schimanski B, Heller M, Roditi I. 2014. Functional charac-
terization of the trypanosome translational repressor SCD6. Biochem J
457:57–67. https://doi.org/10.1042/BJ20130747.
36. Bedford MT, Clarke SG. 2009. Protein arginine methylation in mammals:
who, what, and why. Mol Cell 33:1–13. https://doi.org/10.1016/j.molcel
.2008.12.013.
37. Yang Y, Bedford MT. 2013. Protein arginine methyltransferases and
cancer. Nat Rev Cancer 13:37–50. https://doi.org/10.1038/nrc3409.
38. Auclair Y, Richard S. 2013. The role of arginine methylation in the DNA
damage response. DNA Repair (Amst) 12:459–465. https://doi.org/10
.1016/j.dnarep.2013.04.006.
39. Poulard C, Corbo L, Le Romancer M. 2016. Protein arginine methylation/
demethylation and cancer. Oncotarget 7:67532–67550. https://doi.org/
10.18632/oncotarget.11376.
40. Kim JH, Yoo BC, Yang WS, Kim E, Hong S, Cho JY. 2016. The role of
protein arginine methyltransferases in inﬂammatory responses. Media-
tors Inﬂamm 2016:4028353. https://doi.org/10.1155/2016/4028353.
41. Blanc RS, Richard S. 2017. Arginine methylation: the coming of age. Mol
Cell 65:8–24. https://doi.org/10.1016/j.molcel.2016.11.003.
42. Ferreira TR, Alves-Ferreira EV, Deﬁna TP, Walrad P, Papadopoulou B, Cruz
AK. 2014. Altered expression of an RBP-associated arginine methyltrans-
ferase 7 in Leishmania major affects parasite infection. Mol Microbiol .
https://doi.org/10.1111/mmi.12819.
43. Vickerman K. 1985. Developmental cycles and biology of pathogenic
trypanosomes. Br Med Bull 41:105–114. https://doi.org/10.1093/
oxfordjournals.bmb.a072036.
44. Bauer S, Morris JC, Morris MT. 2013. Environmentally regulated glyco-
some protein composition in the African trypanosome. Eukaryot Cell
12:1072–1079. https://doi.org/10.1128/EC.00086-13.
45. Gifﬁn BF, McCann PP, Bitonti AJ, Bacchi CJ. 1986. Polyamine depletion
following exposure to DL-alpha-diﬂuoromethylornithine both in vivo
and in vitro initiates morphological alterations and mitochondrial acti-
vation in a monomorphic strain of Trypanosoma brucei brucei. J Proto-
zool 33:238–243. https://doi.org/10.1111/j.1550-7408.1986.tb05599.x.
46. Gifﬁn BF, McCann PP. 1989. Physiological activation of the mitochon-
drion and the transformation capacity of DFMO induced intermediate
and short stumpy bloodstream form trypanosomes. Am J Trop Med Hyg
40:487–493. https://doi.org/10.4269/ajtmh.1989.40.487.
47. Tonelli RR, Augusto LDS, Castilho BA, Schenkman S. 2011. Protein syn-
thesis attenuation by phosphorylation of eIF2alpha is required for the
differentiation of Trypanosoma cruzi into infective forms. PLoS One
6:e27904. https://doi.org/10.1371/journal.pone.0027904.
48. Romaniuk MA, Frasch AC, Cassola A. 2018. Translational repression by an
RNA-binding protein promotes differentiation to infective forms in
Trypanosoma cruzi. PLoS Pathog 14:e1007059. https://doi.org/10.1371/
journal.ppat.1007059.
49. Luu VD, Brems S, Hoheisel JD, Burchmore R, Guilbride DL, Clayton C.
2006. Functional analysis of Trypanosoma brucei PUF1. Mol Biochem
Parasitol 150:340–349. https://doi.org/10.1016/j.molbiopara.2006.09
.007.
50. D’Archivio S, Wickstead B. 2017. Trypanosome outer kinetochore pro-
teins suggest conservation of chromosome segregation machinery
across eukaryotes. J Cell Biol 216:379–391. https://doi.org/10.1083/jcb
.201608043.
51. Mony BM, Matthews KR. 2015. Assembling the components of the
quorum sensing pathway in African trypanosomes. Mol Microbiol 96:
220–232. https://doi.org/10.1111/mmi.12949.
Kafková et al. ®
November/December 2018 Volume 9 Issue 6 e02430-18 mbio.asm.org 18
 o
n








52. Estevez AM. 2008. The RNA-binding protein TbDRBD3 regulates the
stability of a speciﬁc subset of mRNAs in trypanosomes. Nucleic Acids
Res 36:4573–4586. https://doi.org/10.1093/nar/gkn406.
53. Erben ED, Fadda A, Lueong S, Hoheisel JD, Clayton C. 2014. A genome-
wide tethering screen reveals novel potential post-transcriptional regu-
lators in Trypanosoma brucei. PLoS Pathog 10:e1004178. https://doi.org/
10.1371/journal.ppat.1004178.
54. Fernández-Moya SM, García-Pérez A, Kramer S, Carrington M, Estévez
AM. 2012. Alterations in DRBD3 ribonucleoprotein complexes in re-
sponse to stress in Trypanosoma brucei. PLoS One 7:e48870. https://doi
.org/10.1371/journal.pone.0048870.
55. Rajyaguru P, She M, Parker R. 2012. Scd6 targets eIF4G to repress
translation: RGG motif proteins as a class of eIF4G-binding proteins. Mol
Cell 45:244–254. https://doi.org/10.1016/j.molcel.2011.11.026.
56. Kilchert C, Weidner J, Prescianotto-Baschong C, Spang A. 2010. Defects
in the secretory pathway and high Ca2 induce multiple P-bodies. Mol
Biol Cell 21:2624–2638. https://doi.org/10.1091/mbc.e10-02-0099.
57. Iwaki A, Izawa S. 2012. Acidic stress induces the formation of P-bodies,
but not stress granules, with mild attenuation of bulk translation in
Saccharomyces cerevisiae. Biochem J 446:225–233. https://doi.org/10
.1042/BJ20120583.
58. Matsumoto K, Nakayama H, Yoshimura M, Masuda A, Dohmae N, Ma-
tsumoto S, Tsujimoto M. 2012. PRMT1 is required for RAP55 to localize
to processing bodies. RNA Biol 9:610–623. https://doi.org/10.4161/rna
.19527.
59. Lien PT, Izumikawa K, Muroi K, Irie K, Suda Y, Irie K. 2016. Analysis of the
physiological activities of Scd6 through its interaction with Hmt1. PLoS
One 11:e0164773. https://doi.org/10.1371/journal.pone.0164773.
60. Poornima G, Shah S, Vignesh V, Parker R, Rajyaguru PI. 2016. Arginine
methylation promotes translation repression activity of eIF4G-binding
protein, Scd6. Nucleic Acids Res 44:9358–9368. https://doi.org/10.1093/
nar/gkw762.
61. Tanaka KJ, Ogawa K, Takagi M, Imamoto N, Matsumoto K, Tsujimoto M.
2006. RAP55, a cytoplasmic mRNP component, represses translation in
Xenopus oocytes. J Biol Chem 281:40096–40106. https://doi.org/10
.1074/jbc.M609059200.
62. Cassola A. 2011. RNA granules living a post-transcriptional life: the
trypanosomes’ case. Curr Chem Biol 5:108–117. https://doi.org/10.2174/
2212796811105020108.
63. Smith TK, Bringaud F, Nolan DP, Figueiredo LM. 2017. Metabolic repro-
gramming during the Trypanosoma brucei life cycle. F1000Res 6:F1000
Faculty Rev-683. https://doi.org/10.12688/f1000research.10342.2.
64. Ortega-Atienza S, Rubis B, McCarthy C, Zhitkovich A. 2016. Formalde-
hyde is a potent proteotoxic stressor causing rapid heat shock transcrip-
tion factor 1 activation and Lys48-linked polyubiquitination of proteins.
Am J Pathol 186:2857–2868. https://doi.org/10.1016/j.ajpath.2016.06
.022.
65. Nwagwu M, Opperdoes FR. 1982. Regulation of glycolysis in Trypano-
soma brucei: hexokinase and phosphofructokinase activity. Acta Trop
39:61–72.
66. Chambers JW, Kearns MT, Morris MT, Morris JC. 2008. Assembly of
heterohexameric trypanosome hexokinases reveals that hexokinase 2 is
a regulable enzyme. J Biol Chem 283:14963–14970. https://doi.org/10
.1074/jbc.M802124200.
67. Wang P, Doxtader KA, Nam Y. 2016. Structural basis for cooperative
function of Mettl3 and Mettl14 methyltransferases. Mol Cell 63:306–317.
https://doi.org/10.1016/j.molcel.2016.05.041.
68. Luciano P, Jeon J, El-Kaoutari A, Challal D, Bonnet A, Barucco M, Candelli
T, Jourquin F, Lesage P, Kim J, Libri D, Géli V. 2017. Binding to RNA
regulates Set1 function. Cell Discov 3:17040. https://doi.org/10.1038/
celldisc.2017.40.
69. Beckmann BM, Horos R, Fischer B, Castello A, Eichelbaum K, Alleaume
AM, Schwarzl T, Curk T, Foehr S, Huber W, Krijgsveld J, Hentze MW. 2015.
The RNA-binding proteomes from yeast to man harbour conserved
enigmRBPs. Nat Commun 6:10127. https://doi.org/10.1038/ncomms
10127.
70. Baltz AG, Munschauer M, Schwanhausser B, Vasile A, Murakawa Y,
Schueler M, Youngs N, Penfold-Brown D, Drew K, Milek M, Wyler E,
Bonneau R, Selbach M, Dieterich C, Landthaler M. 2012. The mRNA-
bound proteome and its global occupancy proﬁle on protein-coding
transcripts. Mol Cell 46:674–690. https://doi.org/10.1016/j.molcel.2012
.05.021.
71. Tsai WC, Gayatri S, Reineke LC, Sbardella G, Bedford MT, Lloyd RE. 2016.
Arginine demethylation of G3BP1 promotes stress granule assembly. J
Biol Chem 291:22671–22685. https://doi.org/10.1074/jbc.M116.739573.
72. Dean S, Sunter J, Wheeler RJ, Hodkinson I, Gluenz E, Gull K. 2015. A
toolkit enabling efﬁcient, scalable and reproducible gene tagging in
trypanosomatids. Open Biol 5:140197. https://doi.org/10.1098/rsob
.140197.
73. Kafková L, Ammerman ML, Faktorova D, Fisk JC, Zimmer SL, Sobotka R,
Read LK, Lukes J, Hashimi H. 2012. Functional characterization of two
paralogs that are novel RNA binding proteins inﬂuencing mitochondrial
transcripts of Trypanosoma brucei. RNA 18:1846–1861. https://doi.org/
10.1261/rna.033852.112.
TbPRMT1 Inﬂuences Metabolism and Stress Response ®
November/December 2018 Volume 9 Issue 6 e02430-18 mbio.asm.org 19
 o
n
 January 3, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
